Carvedilol Tablet, Film Coated
Product Images NDC 71335-1533

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 71335-1533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

A line graph comparing mortality percentages over 21 months between two groups: Carvedilol and Placebo. The x-axis represents time in months, and the y-axis shows percentage mortality. The Carvedilol group exhibits lower mortality rates than the Placebo group throughout the timeline. A statistical significance value (P = 0.0014) is indicated on the graph.*

FDA Label Image

Figure-2 (Figure 2)

A forest plot chart depicting hazard ratios for various subgroups, including men, women, age groups, race, diabetic status, ischemic condition, heart rate categories, systolic blood pressure levels, spironolactone use, and all patients. Each subgroup is represented with a point estimate and confidence interval along a horizontal hazard ratio axis ranging from 0.0 to 2.0, with a vertical reference line at 1.0.*

FDA Label Image

Figure-3 (Figure 3)

A survival analysis Kaplan-Meier plot from the CAPRICORN study comparing mortality rates over 24 months for Carvedilol versus placebo. The y-axis shows percent mortality, and the x-axis shows time in months. Two lines represent mortality trends for placebo and Carvedilol groups, with a p-value of 0.03 indicated.*

FDA Label Image

Figure-4 (Figure 4)

A forest plot titled 'Effects on Mortality for Subgroups in CAPRICORN,' displaying hazard ratios for different patient subgroups. Each subgroup, such as age, gender, timing of randomization post-MI, prior treatment, hypertension, and heart rate, is shown with a dot and confidence interval line. The x-axis ranges from 0.4 to 1.3 hazard ratio, with a vertical line at 1 indicating no effect.*

FDA Label Image

Label Image (Lbl713351128)

Carvedilol 3.125 mg film-coated tablet packaging label. The label indicates a 30-count package from Bryant Ranch Prepack, with storage instructions to keep at room temperature between 20°-25°C (68°-77°F). It also advises to follow doctors' instructions. The label includes an NDC 71335-1128-1 and a barcode.*

FDA Label Image

Label Image (Lbl713351463)

Carvedilol 25 mg tablet label from Bryant Ranch Prepack. The label states the product name and strength, advises to follow doctor's instructions, and includes warnings to store at room temperature (20°-25°C) and keep out of reach of children. It references comparison to Coreg 25 mg tablet by Glenmark Pharmaceuticals Ltd. Additional details include lot number, barcodes, and expiration date placeholder.*

FDA Label Image

Label Image (Lbl713351533)

Carvedilol 12.5 mg film-coated tablets label from Bryant Ranch Prepack. The label indicates packaging of 30 tablets with an NDC of 71335-1533-1. Storage instructions specify room temperature between 20°-25°C (68°-77°F). A barcode and a comparison to Coreg 12.5 mg tablets by Glenmark Pharmaceuticals Limited are also shown.*

FDA Label Image

Carvedilol-chemical-structure (Structure)

Chemical structure of carvedilol, showing its molecular framework with an indole group, hydroxyl, amine, and methoxyphenyl functionalities.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.